Sectors
GenSight Biologics, a ophthalmic therapeutics using gene therapy, has raised $41.8m in series A funding from backers Novartis Venture Fund, Abingworth LLP, Versant Ventures and Index Ventures.
Plant science company ZeaKal has raised $3.8m in series A financing from Finistere Ventures, Two Oceans and the Missouri Soybean Merchandising Council.
The company has partnerships with Amerigroup Florida/WellPoint, Wyckoff Heights Medical Center in New York and Dignity Health in California, and retail pharmacy and public sector initiatives through the City of Louisville.
Novira Therapeutics has expanded its series A round of financing to $25m after an investment of $7.5m from venture capital firm Versant Ventures.
German-based Infrastructure-as-a-service company ProfitBricks has secured a $19.5m investment from its founders United Internet.
US-based QPID has exceed its original target of $3m, by closing a $4m round series A funding from Matrix Partners, Partners Innovation Fund, Massachusetts General Physicians Organization and Cardinal Partners.
Its first deal is Lanica, a US-based mobile game development platform.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
